Episode 201: Doing biotech in Ukraine, drug pricing déjà vu, & Covid surges overseas
The Readout Loud
00:00
The Journal of the Prevention of All Samers Disease
i think it's fair to say that, gardless of one's take on aduhem, this publication didn't change anything. For the people who are certain that it should never have been approved, there was nothing in the paper that seemed to change anyone's mind. And for, for example, biogin, or the many people who believe the drug should be given a chance, i don't think this really advanced either narrative. It's just kind of a box that's now been ticked and then can go back to fighting about the same things the've been fighting about since 20 19.
Transcript
Play full episode
